Position in INCY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,652,397
+$955,979 QoQ
Shares Held
23,398
+29.8% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#300
of 854 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GATEWAY INVESTMENT ADVISERS LLC holds $83,759,285 across 16 Biotechnology names. INCY ranks #3 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
365,000 | $38,916,300 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
67,289 | $33,424,464 | |
| 3 | INCY |
Incyte Corp
This page
|
23,398 | $2,652,397 | |
| 4 | EXEL |
Exelixis, Inc.
|
43,083 | $2,344,146 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
22,728 | $1,300,496 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
4,123 | $993,519 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,900 | $872,987 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
8,111 | $634,847 |
All Filings in INCY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,652,397 | 23,398 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,696,418 | 18,024 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,308,702 | 13,250 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $772,279 | 9,106 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $594,785 | 8,734 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $534,535 | 8,828 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $311,989 | 4,517 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $259,773 | 3,930 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $260,423 | 4,296 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $204,750 | 3,594 | Shares | Sole | 2024-04-12 | |
| No filing history on record for this holder in this stock. | ||||||